All Updates

All Updates

icon
Filter
Funding
Eko Health raises USD 41 million in Series D funding
Preventive Healthcare
Jun 5, 2024
This week:
Robinhood launches joint investment accounts
Retail Trading Infrastructure
Jul 25, 2024
Partnerships
eToro partners with London Stock Exchange to expand UK stock offerings
Retail Trading Infrastructure
Jul 25, 2024
Funding
StorMagic secures funding from Palatine Growth Credit Fund
Edge Computing
Jul 25, 2024
Funding
Archera raises USD 17 million in Series B funding for product development and recruitment
Cloud Optimization Tools
Jul 25, 2024
Funding
Alto Neuroscience receives grant of USD 11.7 million to support Phase IIb clinical trials of ALTO-100
Precision Medicine
Jul 25, 2024
Partnerships
Quest Diagnostics and BD partner to develop flow cytometry-based companion diagnostics for cancer and other diseases
Precision Medicine
Jul 25, 2024
Product updates
USPACE Technology Group Limited unveils commercial optical satellites and related aerospace products
Next-gen Satellites
Jul 25, 2024
Industry news
Sweden issues study on Gripen fighter jet’s satellite launch capability
Next-gen Satellites
Jul 25, 2024
Product updates
Regulation/policy
Terran Orbital receives certification for new manufacturing facility to begin production
Next-gen Satellites
Jul 25, 2024
Partnerships
Crisalion Mobility partners with Air Chateau for pre-order of eVTOL aircraft
Passenger eVTOL Aircraft
Jul 25, 2024
Preventive Healthcare

Preventive Healthcare

Jun 5, 2024

Eko Health raises USD 41 million in Series D funding

Funding

  • Eko Health, a cardiopulmonary digital health company, has successfully raised USD 41 million in a Series D funding round. Participating investors included Artis Ventures, Highland Capital Partners, NTTVC, and Questa Capital. This latest round of funding has brought the company's total funding to USD 165 million.

  • Eko Health intends to use the funds to train its AI algorithms to detect pulmonary conditions such as asthma and pneumonia. The financing will also be used to expand their sales to doctors outside the US.

  • The company notes that, as of June 2024, Eko Health has sold its AI-integrated stethoscope to over a half million healthcare providers.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.